Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TTR | P02766 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 9/20 | 0.44 |
| ▸ | MEN1 | O00255 | 7/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.44 |
| ▸ | LMNA | P02545 | 4/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.41 |
| ▸ | HTT | P42858 | 3/20 | 0.39 |
| ▸ | GLA | P06280 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | XBP1 | P17861 | 1/20 | 0.38 |
| ▸ | CCR6 | P51684 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 2/20 | 0.38 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.38 |
| ▸ | HSPB1 | P04792 | 2/20 | 0.36 |
| ▸ | DRD1 | P21728 | 1/20 | 0.36 |
| ▸ | FBP1 | P09467 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29408318 | 0.82 | MAPT (0.48) | MAPTMEN1KMT2ALMNAALDH1A1 | |
| SCHEMBL855687 | 0.82 | MAPT (0.48) | MAPTMEN1KMT2ALMNAALDH1A1 | |
| SCHEMBL7895387 | 0.81 | TTR (0.62) | TTRMAPTMEN1KMT2ALMNA | |
| SCHEMBL4348680 | 0.81 | TTR (0.46) | TTRMAPTMEN1KMT2ALMNA | |
| SCHEMBL5025160 | 0.78 | ALDH1A1 (0.54) | TTRMAPTMEN1KMT2ALMNA | |
| SCHEMBL29683621 | 0.77 | HSPB1 (0.49) | TTRMAPTMEN1KMT2ALMNA | |
| SCHEMBL2796536 | 0.76 | DRD1 (0.36) | MAPTMEN1KMT2ALMNAALDH1A1 | |
| SCHEMBL29654951 | 0.76 | DRD1 (0.49) | MAPTALDH1A1SMN1; SMN2HTTRAB9A | |
| SCHEMBL3466337 | 0.76 | DRD1 (0.49) | MAPTALDH1A1SMN1; SMN2HTTRAB9A | |
| SCHEMBL5022771 | 0.74 | ESRRA (0.49) | TTRMAPTMEN1KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7511150-B2 | Synthesis of heterocyclic compounds | FOREST LABORATORIES HOLDINGS LIMITED (BM) | 2009-03-31 | — | — | US | claimed |
| WO-2008005955-A9 | SYNTHESIS OF HETEROCYCLIC COMPOUNDS | FOREST LAB HOLDINGS LTD | 2008-04-03 | — | — | WO | claimed |
| US-20080009632-A1 | SYNTHESIS OF HETEROCYCLIC COMPOUNDS | FOREST LABORATORIES HOLDINGS LIMITED (BM) | 2008-01-10 | — | — | US | claimed |
| WO-2008005955-A2 | SYNTHESIS OF HETEROCYCLIC COMPOUNDS | FOREST LABORATORIES HOLDINGS LIMITED (BM) | 2008-01-10 | — | — | WO | claimed |
| US-8580795-B2 | Heterocyclic compounds as phosphodiesterase inhibitors | ORCHID CHEMICALS & PHARMACEUTICALS LIMITED (IN) | 2013-11-12 | — | — | US | disclosed |
| US-8580795-B2 | Heterocyclic compounds as phosphodiesterase inhibitors | ORCHID CHEMICALS & PHARMACEUTICALS LIMITED (IN) | 2013-11-12 | — | — | US | disclosed |
| US-8580795-B2 | Heterocyclic compounds as phosphodiesterase inhibitors | ORCHID CHEMICALS & PHARMACEUTICALS LIMITED (IN) | 2013-11-12 | — | — | US | disclosed |
| US-20110269753-A1 | HETEROCYCLIC COMPOUNDS AS PHOSPHODIESTERASE INHIBITORS | ORCHID RESEARCH LABORATORIES LTD. (IN) | 2011-11-03 | — | — | US | disclosed |
| US-20110269753-A1 | HETEROCYCLIC COMPOUNDS AS PHOSPHODIESTERASE INHIBITORS | ORCHID RESEARCH LABORATORIES LTD. (IN) | 2011-11-03 | — | — | US | disclosed |
| US-20110269753-A1 | HETEROCYCLIC COMPOUNDS AS PHOSPHODIESTERASE INHIBITORS | ORCHID RESEARCH LABORATORIES LTD. (IN) | 2011-11-03 | — | — | US | disclosed |
| EP-2379538-A2 | HETEROCYCLIC COMPOUNDS AS PHOSPHODIESTERASE INHIBITORS | Orchid Research Laboratories Limited (IN) | 2011-10-26 | — | — | EP | disclosed |
| WO-2010084402-A2 | HETEROCYCLIC COMPOUNDS AS PHOSPHODIESTERASE INHIBITORS | ORCHID RESEARCH LABORATORIES LTD. (IN) | 2010-07-29 | — | — | WO | disclosed |
| US-20090143593-A1 | SYNTHESIS OF HETEROCYCLIC COMPOUNDS | FOREST LABORATORIES HOLDINGS LIMITED (BM) | 2009-06-04 | — | — | US | disclosed |
| US-20090143593-A1 | SYNTHESIS OF HETEROCYCLIC COMPOUNDS | FOREST LABORATORIES HOLDINGS LIMITED (BM) | 2009-06-04 | — | — | US | disclosed |
| US-7511150-B2 | Synthesis of heterocyclic compounds | FOREST LABORATORIES HOLDINGS LIMITED (BM) | 2009-03-31 | — | — | US | disclosed |
| US-7511150-B2 | Synthesis of heterocyclic compounds | FOREST LABORATORIES HOLDINGS LIMITED (BM) | 2009-03-31 | — | — | US | disclosed |
| WO-2008005955-A9 | SYNTHESIS OF HETEROCYCLIC COMPOUNDS | FOREST LAB HOLDINGS LTD | 2008-04-03 | — | — | WO | disclosed |
| US-20080009632-A1 | SYNTHESIS OF HETEROCYCLIC COMPOUNDS | FOREST LABORATORIES HOLDINGS LIMITED (BM) | 2008-01-10 | — | — | US | disclosed |
| WO-2008005955-A2 | SYNTHESIS OF HETEROCYCLIC COMPOUNDS | FOREST LABORATORIES HOLDINGS LIMITED (BM) | 2008-01-10 | — | — | WO | disclosed |
| US-20080009632-A1 | SYNTHESIS OF HETEROCYCLIC COMPOUNDS | FOREST LABORATORIES HOLDINGS LIMITED (BM) | 2008-01-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090143593-A1 | SYNTHESIS OF HETEROCYCLIC COMPOUNDS | FDPS, DHPS, AADAC | TTR 4113/4885MAPT 3548/4885MEN1 142/4885 |
| US-20080009632-A1 | SYNTHESIS OF HETEROCYCLIC COMPOUNDS | FDPS, DHPS, AADAC | TTR 4113/4885MAPT 3548/4885MEN1 142/4885 |
| US-20110269753-A1 | HETEROCYCLIC COMPOUNDS AS PHOSPHODIESTERASE INHIBITORS | PDE4A, PDE4B, PDE4C | TTR 1457/4885MAPT 754/4885MEN1 3108/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.